Additionally, immunohistochemical analysis revealed that FA-mExo-siRNA-c-kit successfully inhibited the expression of c-kit in gefitinib-resistant lung cancer xenografts, and the expression of Ki67 in the tumor tissues of the combined treatment group of mice was significantly reduced (Figure 5E). Here, KIT is linked to lung cancer.